Novozymes reported 149.72M in Cash and Equivalent for its fiscal quarter ending in December of 2023.





Cash And Equivalent Change Date
Arq USD 4.67M 1.9M Mar/2026
Avient USD 427.6M 82.9M Mar/2026
Chemours USD 563M 107M Mar/2026
Coronado Global Resources USD 229.7M 109.92M Mar/2025
Corteva USD 1.96B 2.56B Mar/2026
Metallus USD 104M 52.7M Mar/2026
Newmont Corporation USD 5.64B 546M Sep/2025
Novozymes 149.72M 7.92M Dec/2023
SSR Mining USD 634.09M 99.25M Mar/2026